 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | Psilocybin Therapy for depression / HighBrid Lab
Trial completion date, Trial primary completion date: Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder (clinicaltrials.gov) - Jan 10, 2023
P2, N=20, Active, not recruiting, Sponsor: Halucenex Life Sciences Inc.
Trial completion date: Mar 2023 --> Sep 2023 | Trial primary completion date: Dec 2022 --> Jun 2023
- | Psilocybin Therapy for depression / HighBrid Lab
Enrollment closed: Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder (clinicaltrials.gov) - Oct 4, 2022
P2, N=20, Active, not recruiting, Sponsor: Halucenex Life Sciences Inc.
Trial completion date: Mar 2023 --> Sep 2023 | Trial primary completion date: Dec 2022 --> Jun 2023 Recruiting --> Active, not recruiting
- || Psilocybin Therapy for depression / HighBrid Lab
Enrollment open: Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder (clinicaltrials.gov) - Sep 10, 2022
P2, N=20, Recruiting, Sponsor: Halucenex Life Sciences Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Psilocybin Therapy for depression / HighBrid Lab
Trial completion date, Trial initiation date, Trial primary completion date: Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder (clinicaltrials.gov) - Jul 29, 2022
P2, N=20, Not yet recruiting, Sponsor: Halucenex Life Sciences Inc.
Not yet recruiting --> Recruiting Trial completion date: Nov 2022 --> Mar 2023 | Initiation date: Apr 2022 --> Sep 2022 | Trial primary completion date: May 2022 --> Dec 2022
- | Psilocybin Therapy for depression / HighBrid Lab
New P2 trial: Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder (clinicaltrials.gov) - Feb 17, 2022
P2, N=20, Not yet recruiting, Sponsor: Halucenex Life Sciences Inc.